Identifying healthy individuals with Alzheimer’s disease neuroimaging phenotypes in the UK Biobank
Abstract Background Identifying prediagnostic neurodegenerative disease is a critical issue in neurodegenerative disease research, and Alzheimer’s disease (AD) in particular, to identify populations suitable for preventive and early disease-modifying trials. Evidence from genetic and other studies s...
Main Authors: | Tiago Azevedo, Richard A. I. Bethlehem, David J. Whiteside, Nol Swaddiwudhipong, James B. Rowe, Pietro Lió, Timothy Rittman, the Alzheimer’s Disease Neuroimaging Initiative |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-07-01
|
Series: | Communications Medicine |
Online Access: | https://doi.org/10.1038/s43856-023-00313-w |
Similar Items
-
Brain Entropy Mapping in Healthy Aging and Alzheimer’s Disease
by: Ze Wang, et al.
Published: (2020-11-01) -
Neuroimaging modality fusion in Alzheimer's classification using convolutional neural networks.
by: Arjun Punjabi, et al.
Published: (2019-01-01) -
Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer's disease neuroimaging initiative.
by: Xiaohui Yao, et al.
Published: (2017-01-01) -
Association of peripheral immunity with cognition, neuroimaging, and Alzheimer’s pathology
by: Jia-Hui Hou, et al.
Published: (2022-02-01) -
Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer's Disease Neuroimaging (ADNI) database.
by: Juan Felipe Beltrán, et al.
Published: (2020-01-01)